<![CDATA[Roundup: FDA Approves Lilly’s Olumiant, AbbVie’s Juvmo, Mirum & Incyte’s Atebrioz ]]>
A practical brief for this story from Pharmexec.
![<![CDATA[Roundup: FDA Approves Lilly’s Olumiant, AbbVie’s Juvmo, Mirum & Incyte’s Atebrioz ]]>](/api/proxy/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fpharmexec%2F002a8e7fe609de4e9bfc4962be072ff719056cf4-1280x720.jpg)
Building the complete brief
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
The useful part
Pharmexec covered <![CDATA[Roundup: FDA Approves Lilly’s Olumiant, AbbVie’s Juvmo, Mirum & Incyte’s Atebrioz ]]>.
Keep reading in the app
Open the app view to save this story, compare related coverage, and continue from the same source.